JP2003514576A5 - - Google Patents

Download PDF

Info

Publication number
JP2003514576A5
JP2003514576A5 JP2001540121A JP2001540121A JP2003514576A5 JP 2003514576 A5 JP2003514576 A5 JP 2003514576A5 JP 2001540121 A JP2001540121 A JP 2001540121A JP 2001540121 A JP2001540121 A JP 2001540121A JP 2003514576 A5 JP2003514576 A5 JP 2003514576A5
Authority
JP
Japan
Prior art keywords
hcv
virus
immunogenic
particle
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001540121A
Other languages
English (en)
Japanese (ja)
Other versions
JP4647870B2 (ja
JP2003514576A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/032249 external-priority patent/WO2001038358A2/en
Publication of JP2003514576A publication Critical patent/JP2003514576A/ja
Publication of JP2003514576A5 publication Critical patent/JP2003514576A5/ja
Application granted granted Critical
Publication of JP4647870B2 publication Critical patent/JP4647870B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

JP2001540121A 1999-11-24 2000-11-22 Ｈｂｖ／ｈｃｖウイルス様粒子 Expired - Lifetime JP4647870B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16722499P 1999-11-24 1999-11-24
US60/167,224 1999-11-24
PCT/US2000/032249 WO2001038358A2 (en) 1999-11-24 2000-11-22 Hbv/hcv virus-like particle

Publications (3)

Publication Number Publication Date
JP2003514576A JP2003514576A (ja) 2003-04-22
JP2003514576A5 true JP2003514576A5 (https=) 2008-01-10
JP4647870B2 JP4647870B2 (ja) 2011-03-09

Family

ID=22606465

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001540121A Expired - Lifetime JP4647870B2 (ja) 1999-11-24 2000-11-22 Ｈｂｖ／ｈｃｖウイルス様粒子

Country Status (8)

Country Link
EP (1) EP1233783B9 (https=)
JP (1) JP4647870B2 (https=)
AT (1) ATE290399T1 (https=)
AU (1) AU1928201A (https=)
CA (1) CA2392527C (https=)
DE (2) DE60018601D1 (https=)
ES (1) ES2430368T3 (https=)
WO (1) WO2001038358A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002339224B2 (en) 2001-09-14 2008-10-09 Kuros Us Llc Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
JP4502642B2 (ja) * 2002-02-07 2010-07-14 メルボルン ヘルス ヌクレオシドアナログに対する感受性の変化を有するウイルス変種およびその使用
DE10218129A1 (de) * 2002-04-23 2003-11-20 Univ Ruprecht Karls Heidelberg Genetischer Impfstoff gegen RNA-Virus-Infektionen
WO2004110482A1 (en) * 2003-06-13 2004-12-23 Isis Innovation Limited Improved vaccines
EP1973608A1 (en) 2005-12-14 2008-10-01 Cytos Biotechnology AG Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
MX2008015529A (es) 2006-06-12 2009-01-13 Cytos Biotechnology Ag Procesos para empacar oligonucleotidos en particulas similares a virus de bacteriofagos de arn.
US20080166785A1 (en) * 2006-08-16 2008-07-10 Monica Sala-Schaeffer Polynucleotides allowing the expression and secretion of recombinant HBsAg virus-like particles containing a foreign peptide, their production and use
CA2671873C (en) 2006-12-12 2018-10-09 Brian Stephen Sproat Oligonucleotides containing high concentrations of guanine monomers
FR2932388B1 (fr) * 2008-06-17 2013-03-29 Univ Rabelais Francois Nouvelles proteines de fusion et leur application pour la preparation de vaccins contre l'hepatite c
US9238679B2 (en) * 2011-02-11 2016-01-19 The Trustees Of The University Of Pennslyvania Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
JP2014212722A (ja) * 2013-04-24 2014-11-17 学校法人加計学園 八面体構造を有するｂ型肝炎ウイルス様粒子結晶
EA202091513A1 (ru) 2017-12-19 2020-09-09 Янссен Сайенсиз Айрлэнд Анлимитед Компани Вакцины против вируса гепатита b (hbv) и их применение
TW202245809A (zh) * 2020-12-18 2022-12-01 美商詹森藥物公司 用於治療b型肝炎病毒感染之組合療法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098704A (en) * 1984-06-18 1992-03-24 Chiron Corporation Hepatitis surface antigen particle vaccine
FR2581394B1 (fr) * 1985-05-02 1988-08-05 Grp Genie Genetique Particules ayant les proprietes immunogenes de l'antigene hbs et portant un site antigenique etranger aux epitopes portes par l'antigene hbs, vecteurs et cellules animales pour la production de telles particules et compositions contenant de telles particules pour la production de vaccins mixtes
KR970010787A (ko) * 1995-08-14 1997-03-27 성재갑 B형 간염 바이러스 표면항원과 c형 간염 바이러스 외피 단백질의 융합 단백질 및 이를 포함하는 혼합 백신

Similar Documents

Publication Publication Date Title
Lazdina et al. Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent
ES2213754T3 (es) Particulas quimericas de tipo papilomavirus.
Clarke et al. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein
EP1037917B1 (en) Recombinant nodavirus compositions and methods
JP2003514576A5 (https=)
CA2405438A1 (en) Hepatitis b core antigen fusion proteins
Wizemann et al. Purification of E. coli-expressed HIS-tagged hepatitis B core antigen by Ni2+-chelate affinity chromatography
JP2006523189A5 (https=)
Ulrich et al. New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge
JPS63196293A (ja) 融合蛋白
Sominskaya et al. A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice
Beames et al. Carboxy-terminal truncations of the HBV core protein affect capsid formation and the apparent size of encapsidated HBV RNA
JP2008074867A (ja) ペプチドリガンドを介して結合された複数の免疫原性成分を有するｈｂｖコア抗原粒子
Koletzki et al. HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein
EP1780285A1 (en) Improved virus like particles (VLP) based on the small envelope protein of hepatitis B virus (HBsAg-S)
NZ541702A (en) Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis
JPH0327400A (ja) Ｂ型肝炎ウイルスコア抗原粒子
Mihailova et al. Recombinant virus-like particles as a carrier of B-and T-cell epitopes of hepatitis C virus (HCV)
Freivalds et al. Assembly of bacteriophage Qβ virus-like particles in yeast Saccharomyces cerevisiae and Pichia pastoris
JP2004501646A5 (https=)
Borisova et al. Spatial structure and insertion capacity of immunodominant region of hepatitis B core antigen
JP5656832B2 (ja) 新規な融合タンパク質及びｃ型肝炎ワクチンの製造のためのその使用
CN101036784B (zh) 一种乙型肝炎治疗性细胞毒性t细胞表位疫苗及其制备方法
KR101250029B1 (ko) Ｈｂｖ 감염 또는 ｈｂｖ-매개 질병의 예방/치료를 위한조성물
WO2001038358A3 (en) Hbv/hcv virus-like particle